L DESIGN
"L DESIGN" is a figurative mark owned by Eli Lilly and Company, filed at the CIPO on November 21, 2023. It is registered and covers classes 5 and 44.
- Status
- Registered
- Since December 12, 2025
- Filed
- November 21, 2023
- Registered
- December 12, 2025
- Expires
- December 12, 2035
- Application no.
- 2293988
- Registration no.
- TMA1367388
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Figurative mark
- 2 classes
Who owns L DESIGN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Eli Lilly and Company
LLY · United States
Representative
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
What the mark covers
The products and services L DESIGN is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of bursitis, tendonitis and osteonecrosis; pharmaceutical preparations for the treatment of depression, bipolar depression, and cognitive impairment associated with schizophrenia; pharmaceutical preparations for the treatment of cluster headaches and migraines; pharmaceutical preparations for the treatment of rheumatoid arthritis, psoriatic arthritis, lupus and spondyloarthropathy; pharmaceutical preparations for the treatment of muscle diseases and disorders namely myopathies, chronic fatigue syndrome and fibromyalgia; diagnostic reagents for medical diagnostic use; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for the diagnosis of oncological diseases and disorders; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment and the prevention of dementia; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, ulcerative colitis; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of mental health disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treatment of autoimmune diseases and disorders; radiopharmaceutical preparations for diagnostic purposes;
Providing health and medical information in the field of oncology; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing information relating to the preparation and dispensing of medications; providing information to patients in the field of administering medications; providing medical information in the field of autoimmune diseases and disorders; providing medical information in the field of cancer treatment; providing medical information in the field of endocrinology; providing medical information in the field of gastroenterology; providing medical information in the field of inflammatory bowel disease; providing medical information in the field of pharmaceutical preparations for the treatment of headaches; providing medical information in the treatment and prevention of endocrine diseases and disorders; providing medical information in the treatment and prevention of metabolic diseases and disorders;
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Pending
- Advertised; Vol.72 Issue 3700
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Search Recorded
- Pre-Assessment Letter Sent; Retired Goods or Services
- Formalized
- Created
- Filed
About L DESIGN
Who owns the trademark "L DESIGN"?
The CIPO trademark "L DESIGN" (application 2293988) is owned by Eli Lilly and Company.
What is the status of "L DESIGN"?
Its status at the CIPO is: registered.
When was "L DESIGN" registered?
It was registered on December 12, 2025 and is due to expire on December 12, 2035.
Get this data via the API
Everything on this page comes from the Signa API. Pull L DESIGN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb3d-1525-734c-937d-8e5729e2cb53
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb3d-1525-734c-937d-8e5729e2cb53",
"object": "trademark",
"mark_text": "L DESIGN",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "2293988",
"filing_date": "2023-11-21",
"nice_classes": [
5,
44
],
"owners": [
{
"name": "ELI LILLY AND COMPANY",
"entity_id": "ent_019f286c-97ee-774b-84b5-7d5dc09e0b99"
}
]
}